![]()
|
|
||||||||
(Received for publication, February 15, 1996)
From the Most insulin-like growth factor (IGF) molecules
in the circulation are found in a 150-kDa complex containing
IGF-binding protein-3 (IGFBP-3) and an acid-labile subunit, which does
not itself bind IGF. Affinities (Kd values) between
0.03 and 0.5 nM have been reported for IGF-I/IGFBP-3
binding, but no kinetic data are available. In this study we measured
the high affinity binding of unlabeled IGFs and IGF analogues to
recombinant unglycosylated IGFBP-3, using a BIAcoreTM instrument
(Pharmacia Biosensor AB). IGF-I binding showed fast association and
slow non-first-order dissociation kinetics, and an equilibrium
Kd of 0.23 nM. IGF-II had similar
kinetics with slightly higher affinity. Analogues with mutations in the
first 3 amino acids of the B-region (des(, , ) IGF-I and long IGF-I)
showed 25 and 50 times lower affinity than IGF-I. Replacement of
residues 28-37 by Gly-Gly-Gly-Gly or deletion of residues 29-41 in
the C-region had little effect on the kinetic parameters, contrasting
with the markedly impaired binding of these analogues to the IGF-I
receptor. Swapping of the disulfide bridges in IGF-I and the C-region
mutants decreased the affinity dramatically for IGFBP-3, primarily by
decreasing the association rate. Insulin had approximately 1000 times
lower affinity than IGF-I.
Volume 271, Number 24,
Issue of June 14, 1996
pp. 13948-13952
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
,
and
Hagedorn Research Institute, Niels Steensens
Vej 6, DK-2820 Gentofte, Denmark, the § Department of
Crystallography, Birkbeck College, Malet Street, London WC1E 7HX,
United Kingdom, and ¶ Celtrix Pharmaceuticals, Inc.,
Santa Clara, California 95052
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Denley, C. C. Wang, K. A. McNeil, M. J. E. Walenkamp, H. van Duyvenvoorde, J. M. Wit, J. C. Wallace, R. S. Norton, M. Karperien, and B. E. Forbes Structural and Functional Characteristics of the Val44Met Insulin-Like Growth Factor I Missense Mutation: Correlation with Effects on Growth and Development Mol. Endocrinol., March 1, 2005; 19(3): 711 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Beattie, K. Phillips, J. H Shand, M. Szymanowska, D. J Flint, and G. J Allan Molecular recognition characteristics in the insulin-like growth factor (IGF)-insulin-like growth factor binding protein -3/5 (IGFBP-3/5) heparin axis J. Mol. Endocrinol., February 1, 2005; 34(1): 163 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Yan, B. E. Forbes, K. A. McNeil, R. C. Baxter, and S. M. Firth Role of N- and C-terminal Residues of Insulin-like Growth Factor (IGF)-binding Protein-3 in Regulating IGF Complex Formation and Receptor Activation J. Biol. Chem., December 17, 2004; 279(51): 53232 - 53240. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. D. Payet, X.-H. Wang, R. C. Baxter, and S. M. Firth Amino- and Carboxyl-Terminal Fragments of Insulin-Like Growth Factor (IGF) Binding Protein-3 Cooperate to Bind IGFs with High Affinity and Inhibit IGF Receptor Interactions Endocrinology, July 1, 2003; 144(7): 2797 - 2806. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vorwerk, B. Hohmann, Y. Oh, R. G. Rosenfeld, and R. M. Shymko Binding Properties of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3), IGFBP-3 N- and C-Terminal Fragments, and Structurally Related Proteins mac25 and Connective Tissue Growth Factor Measured Using a Biosensor Endocrinology, May 1, 2002; 143(5): 1677 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Pulford and D. N. Ishii Uptake of Circulating Insulin-Like Growth Factors (IGFs) into Cerebrospinal Fluid Appears to Be Independent of the IGF Receptors as Well as IGF-Binding Proteins Endocrinology, January 1, 2001; 142(1): 213 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Campbell, S. K. Durham, J. D. Hayes, A. Suwanichkul, and D. R. Powell Insulin-like Growth Factor-binding Protein-3 Binds Fibrinogen and Fibrin J. Biol. Chem., October 15, 1999; 274(42): 30215 - 30221. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Patel, E. C. M. B.-V. d. Linden, S. W. Altmann, K. Gish, S. Balasubramanian, J. C. Timans, D. Peterson, M. P. Bell, J. F. Bazan, A. Varki, et al. OB-BP1/Siglec-6. A LEPTIN- AND SIALIC ACID-BINDING PROTEIN OF THE IMMUNOGLOBULIN SUPERFAMILY J. Biol. Chem., August 6, 1999; 274(32): 22729 - 22738. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Campbell, S. K. Durham, A. Suwanichkul, J. D. Hayes, and D. R. Powell Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3 Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E321 - E331. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Hobba, A. Lothgren, E. Holmberg, B. E. Forbes, G. L. Francis, and J. C. Wallace Alanine Screening Mutagenesis Establishes Tyrosine 60 of Bovine Insulin-like Growth Factor Binding Protein-2 as a Determinant of Insulin-like Growth Factor Binding J. Biol. Chem., July 31, 1998; 273(31): 19691 - 19698. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Forbes, D. Turner, S. J. Hodge, K. A. McNeil, G. Forsberg, and J. C. Wallace Localization of an Insulin-like Growth Factor (IGF) Binding Site of Bovine IGF Binding Protein-2 Using Disulfide Mapping and Deletion Mutation Analysis of the C-terminal Domain J. Biol. Chem., February 20, 1998; 273(8): 4647 - 4652. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haniu, S. Montestruque, E. J. Bures, J. Talvenheimo, R. Toso, S. Lewis-Sandy, A. A. Welcher, and M. F. Rohde Interactions between Brain-derived Neurotrophic Factor and the TRKB Receptor. IDENTIFICATION OF TWO LIGAND BINDING DOMAINS IN SOLUBLE TRKB BY AFFINITY SEPARATION AND CHEMICAL CROSS-LINKING J. Biol. Chem., October 3, 1997; 272(40): 25296 - 25303. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Karas, M. Danilenko, D. Fishman, D. LeRoith, J. Levy, and Y. Sharoni Membrane-associated Insulin-like Growth Factor-binding Protein-3 Inhibits Insulin-like Growth Factor-I-induced Insulin-like Growth Factor-I Receptor Signaling in Ishikawa Endometrial Cancer Cells J. Biol. Chem., June 27, 1997; 272(26): 16514 - 16520. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Imai, A. Moralez, U. Andag, J. B. Clarke, W. H. Busby Jr., and D. R. Clemmons Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions J. Biol. Chem., June 9, 2000; 275(24): 18188 - 18194. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |